drugset / Trial / NCT01661855

A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD

NCT01661855

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will examine the potential efficacy and safety of riluzole for core and associated symptom domains of autism and will explore biological markers of safety and treatment response.

Timeline

Start
2013-09
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riluzole Small molecule 50 mg